BEP regimen
|
WikiDoc Resources for BEP regimen |
|
Articles |
|---|
|
Most recent articles on BEP regimen Most cited articles on BEP regimen |
|
Media |
|
Powerpoint slides on BEP regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on BEP regimen at Clinical Trials.gov Clinical Trials on BEP regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on BEP regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on BEP regimen Discussion groups on BEP regimen Patient Handouts on BEP regimen Directions to Hospitals Treating BEP regimen Risk calculators and risk factors for BEP regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for BEP regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: BEP; BEP Regimen; BEP regimen; Bleomycin-Etoposide-Platinol Regimen; PEB Regimen; Platinol-Etoposide-Bleomycin Regimen
Overview
BEP regimen refers to a regimen consisting of bleomycin, etoposide and cisplatin(Platinol) used to treat advanced-stage ovarian and testicular germ-cell tumors.[1][2]
Regimen
Indications
References
- ↑ "NCI Thesaurus".
- ↑ "R-CHOP - National Cancer Institute".
- ↑ 3.0 3.1 Satoh T, Aoki Y, Kasamatsu T, Ochiai K, Takano M, Watanabe Y; et al. (2015). "Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour". Eur J Cancer. 51 (3): 340–51. doi:10.1016/j.ejca.2014.12.004. PMID 25559616.